```html

Laryngotracheal Stenosis – A Patient‑Friendly Medical Guide

Overview

Laryngotracheal stenosis (LTS) is a narrowing of the airway that includes the larynx (voice box) and the trachea (windpipe). The constriction may be short or long, partial or complete, and it impedes the normal flow of air in and out of the lungs. Because the airway is essential for breathing, speaking, and swallowing, LTS can have a profound impact on daily life.

Who it affects: LTS can occur at any age, but the epidemiology differs by cause. In the United States, an estimated 4–6 per 100,000 people develop clinically significant LTS each year, with a slight male predominance (≈55 %). Pediatric cases are most often linked to prolonged intubation, while adult cases are frequently associated with autoimmune disease, trauma, or prior airway surgery (Mayo Clinic, 2023; WHO, 2022).

Symptoms

The presentation varies according to the severity and location of the stenosis. Most patients experience a combination of the following:

• Dyspnea (shortness of breath) – worsens with exertion, speaking, or lying flat.
• Stridor – a high‑pitched, whistle‑like sound heard during inspiration; may become audible at rest in severe cases.
• Hoarseness or voice changes – a breathy, weak, or raspy voice.
• Cough – dry or bark‑like; often worse at night.
• Wheezing – may be mistaken for asthma.
• Difficulty swallowing (dysphagia) – especially liquids if the narrowing extends into the upper trachea.
• Sensation of “tightness” in the throat or a feeling that something is stuck.
• Exercise intolerance – fatigue or breathlessness after minimal activity.
• Frequent respiratory infections – due to impaired clearance of secretions.
• Chronic throat clearing or the need to cough to clear mucus.

In advanced stenosis, symptoms may progress to respiratory distress, cyanosis, or loss of consciousness.

Causes and Risk Factors

Primary (idiopathic) LTS

In about 20–30 % of adult cases, no clear cause is identified. These patients often have a history of mild upper‑respiratory infections and may have subtle autoimmune activity.

Acquired Causes

• Prolonged endotracheal intubation or tracheostomy – pressure from the tube cuff can damage the mucosa, leading to scar formation. This is the most common cause in children and in critically ill adults (CDC, 2021).
• Trauma – blunt or penetrating injuries to the neck, burns, or surgical manipulation.
• Inflammatory/autoimmune diseases – granulomatosis with polyangiitis (Wegener’s), relapsing polychondritis, sarcoidosis, and rheumatoid arthritis can cause progressive subglottic fibrosis.
• Infections – tuberculosis, fungal infections (e.g., histoplasmosis), and severe viral laryngitis may scar the airway.
• Radiation therapy – for head and neck cancers; fibrosis may develop months to years later.
• Neoplasms – benign (e.g., papillomatosis) or malignant tumors that encroach on the airway.

Risk Factors

• Age > 50 years (higher risk for autoimmune and radiation‑related LTS).
• Male sex (slightly higher incidence).
• Prolonged mechanical ventilation (> 48 h) or high cuff pressures.
• History of neck surgery, especially thyroidectomy or laryngeal framework procedures.
• Smoking and chronic irritant exposure (e.g., occupational dust).
• Pre‑existing inflammatory disorders.

Diagnosis

Because early symptoms mimic asthma or chronic bronchitis, a high index of suspicion is required.

Clinical Evaluation

• Detailed history focusing on prior intubation, surgeries, autoimmune disease, and symptom progression.
• Physical exam with attention to voice quality, breathing pattern, and presence of stridor.

Imaging and Endoscopic Tests

• Flexible laryngoscopy – bedside visualization of the larynx and upper trachea; can grade the degree of narrowing.
• Rigid bronchoscopy – gold standard for direct measurement of lumen diameter, assessment of mucosal pliability, and ability to perform therapeutic interventions.
• Computed tomography (CT) of the neck and chest – provides cross‑sectional anatomy, identifies extrinsic compression, and helps in surgical planning.
• Dynamic airway ultrasound – emerging modality for pediatric assessment.
• Pulmonary function tests (PFTs) – may show a flow‑volume loop consistent with extrathoracic obstruction (flattened inspiratory curve).

Classification

Stenosis is graded by the Myer‑Cotton system (used for subglottic stenosis) or the Cotton‑Myer classification for tracheal disease, based on the percentage of airway obstruction:

• Grade I – < 30 % obstruction
• Grade II – 30–50 %
• Grade III – 51–70 %
• Grade IV – > 70 % (often requires urgent intervention)

Treatment Options

Management is individualized, taking into account stenosis grade, location, patient comorbidities, and functional goals.

Conservative Measures

• Humidified air and nebulized saline – keeps mucosa moist, reduces crust formation.
• Voice therapy – speech‑language pathologists can improve vocal efficiency and reduce strain.
• Avoidance of irritants – smoking cessation, protection from occupational dust.

Medical Therapy

• Topical corticosteroids (e.g., budesonide nebulizer) – may slow scar formation in early, inflammatory cases.
• Systemic steroids – short courses for acute flare‑ups related to autoimmune disease.
• Immunomodulatory agents (e.g., methotrexate, azathioprine) – used when an underlying autoimmune condition is identified.
• Antibiotics – for secondary bacterial infection; not a treatment for stenosis itself.

Surgical & Interventional Options

1. Endoscopic dilation – heated balloon or rigid dilators expand the narrowed segment; typically repeated every 3–6 months for moderate disease.
2. Laser or electrocautery excision – removes scar tissue before dilation.
3. Cricotracheal resection (CTR) – definitive surgical removal of the stenotic segment with primary anastomosis; success rates > 90 % for short, well‑localized lesions (Cleveland Clinic, 2022).
4. Tracheal reconstruction with grafts – autologous cartilage or rib grafts for extensive stenosis.
5. Stent placement – silicone or metal stents maintain patency; reserved for patients who are not surgical candidates.
6. Adjunctive Mitomycin‑C topical application – anti‑fibrotic agent used intra‑operatively; evidence suggests reduced restenosis rates.

Post‑procedure Care

• Voice rest for 24‑48 h after endoscopic work.
• Proton‑pump inhibitor (PPI) therapy to minimize reflux‑related airway irritation.
• Regular follow‑up laryngoscopy every 3–6 months during the first year.

Living with Laryngotracheal Stenosis

Daily Management Tips

• Hydration – aim for at least 2 liters of water daily; humidifiers are helpful in dry climates.
• Breathing techniques – diaphragmatic breathing and pursed‑lip breathing reduce airway resistance.
• Exercise cautiously – start with low‑impact activities (walking, swimming) and monitor for increased dyspnea.
• Voice conservation – avoid yelling, use amplification devices when speaking in groups.
• Medication adherence – never skip prescribed steroids or immunosuppressants without consulting your provider.
• Air quality – use HEPA filters at home; avoid second‑hand smoke and strong fragrances.
• Nutrition – soft, easy‑to‑swallow foods reduce choking risk; consider a dietitian if dysphagia is present.
• Emergency plan – keep a list of contacts, hospital location, and your airway‑related medical history on you at all times.

Psychosocial Support

Living with chronic airway narrowing can be stressful. Consider joining support groups (e.g., American Laryngological Association patient network) and seeking counseling if anxiety or depression arises.

Prevention

• Careful airway management – During surgery or intensive‑care ventilation, use the lowest effective cuff pressure (<20 cm H₂O) and limit intubation duration when possible.
• Prompt treatment of upper‑respiratory infections – Reduces inflammation that can precipitate scar formation.
• Manage gastroesophageal reflux disease (GERD) – Chronic acid exposure worsens airway inflammation; lifestyle changes and PPIs are recommended.
• Smoking cessation – Eliminates a major irritant and improves overall healing.
• Regular follow‑up after airway surgery – Early detection of narrowing allows less invasive treatment.

Complications

If untreated or inadequately managed, LTS can lead to:

• Progressive respiratory failure – due to chronic hypoxia.
• Chronic cough and recurrent infections – from impaired clearance of secretions.
• Permanent voice loss or severe dysphonia.
• Tracheostomy dependence – some patients require a permanent tracheostomy for airway protection.
• Psychological impact – anxiety, social isolation, and reduced quality of life.
• Complications of repeated interventions – granulation tissue formation, stent migration, or airway perforation.

When to Seek Emergency Care

References

• Mayo Clinic. “Laryngeal stenosis.” 2023. mayoclinic.org
• Centers for Disease Control and Prevention. “Ventilator-associated complications.” 2021. cdc.gov
• World Health Organization. “Global burden of airway diseases.” 2022. who.int
• Cleveland Clinic. “Cricotracheal resection for subglottic stenosis.” 2022. clevelandclinic.org
• National Institutes of Health. “Management of airway stenosis.” 2023. nih.gov

```